Concepedia

Olivia Coughlin

OC

4

Publications

201

Citations

4

H-Index

2016

Active since

Affiliations

Synthetic Biologics (United States)(Current)

Olivia Coughlin is an author at Synthetic Biologics (United States) specializing in bacterial pathogens, clinical microbiology, and antibiotics.

Top concepts

Publications per year

2016–2019

4

Publications

4

Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial

John F. Kokai‐Kun, Tracey Roberts, Olivia Coughlin et al. · The Lancet Infectious Diseases · 2019 · 82 citations

, , +11

The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies

John F. Kokai‐Kun, Tracey Roberts, Olivia Coughlin et al. · Antimicrobial Agents and Chemotherapy · 2017 · 63 citations · Full text

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies

Tracey Roberts, John F. Kokai‐Kun, Olivia Coughlin et al. · Clinical Drug Investigation · 2016 · 30 citations

, , +12

Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation

Steven Hubert, A. V. Chadwick, Vince Wacher et al. · Journal of Pharmaceutical Sciences · 2017 · 26 citations · Full text

Rows per page

1–4 of 4